Mnemo lures Bayer oncology business chief as new CEO to lead CAR-T work
Mnemo lures Bayer oncology business chief as new CEO to [...]
Kodiak’s Eylea rival hits ‘major disappointment’ with failure in first of 6 phase 3 studies
Kodiak’s Eylea rival hits ‘major disappointment’ with failure in first [...]
Sanofi, GSK post 58% efficacy in omicron-affected COVID-19 vaccine trial, teeing up race to regulators
Sanofi, GSK post 58% efficacy in omicron-affected COVID-19 vaccine trial, [...]
Stability woes torpedo Marinus’ phase 3 seizure timeline, combining with COVID-19 to cause one-year delay
Stability woes torpedo Marinus’ phase 3 seizure timeline, combining with [...]
Adagio CEO resigns with no explanation and the biotech plans COVID-19 antibody analysis this quarter
Adagio CEO resigns with no explanation and the biotech plans [...]
Building off Prevail buy, Lilly to construct $700 million Boston research hub in gene therapy blitz
Building off Prevail buy, Lilly to construct $700 million Boston [...]
Moderna’s RSV shot sails on to phase 3, tightening Big Pharma battle royale
Moderna’s RSV shot sails on to phase 3, tightening Big [...]
Atara, Memorial Sloan Kettering investigating patient death in phase 1 mesothelioma CAR-T study
Atara, Memorial Sloan Kettering investigating patient death in phase 1 [...]
Ribon taps former Novartis VP, Flagship partner Raman as CEO
Ribon taps former Novartis VP, Flagship partner Raman as CEO [...]
Ligand to spin off J&J-partnered antibody unit with $70M in funding
Ligand to spin off J&J-partnered antibody unit with $70M in [...]